Inovio pharmaceuticals ceo
WebApr 12, 2024 · INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at … WebNov 5, 2024 · Effective immediately, four experienced and talented leaders will all join the executive team and report to INOVIO's President and CEO, Dr. J. Joseph Kim. Dr. Kim said, …
Inovio pharmaceuticals ceo
Did you know?
WebMay 10, 2024 · Inovio Pharmaceuticals Inc will discontinue a late-stage study of its COVID-19 vaccine, the company said on Tuesday, and appointed its operating chief as the new chief executive, sending the ... Web1 day ago · Shares of Inovio Pharmaceuticals Inc. INO, -9.05% shed 9.05% to $0.85 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index...
WebMay 10, 2024 · The company's net loss of $79.1M in the quarter compares to a loss of $54.4M in Q1 2024. Inovio ( INO) also used its earnings release to state that Jacquelimne Shea has taken over as CEO,... WebFor its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. Board of Directors in INOVIO PHARMACEUTICALS, INC. For its 2024 fiscal year, INOVIO PHARMACEUTICALS, INC., listed the following board members on its annual proxy statement to the SEC.
WebMar 31, 2024 · J. Kim became the CEO of Inovio Pharmaceuticals, Inc. ( NASDAQ:INO) in 2009. This analysis aims first to contrast CEO compensation with other companies that … WebExhibit 10.12 . FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT . THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of September 28, 2011 (“Effective Date”), between OncoSec Medical Incorporated, a Nevada corporation (the “Purchaser”), and Inovio Pharmaceuticals, Inc. (the “Company”), a …
WebApr 10, 2024 · Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), …
WebJACQUELINE SHEA, Ph.D. PRESIDENT & CHIEF EXECUTIVE OFFICER “We are entering a new era in DNA medicines and INOVIO is forging the path by bringing a 21st century approach … the sheep don\u0027t like it rock the cat boxWebFeb 4, 2024 · Inovio Pharmaceuticals Inc has a market cap of $2.98 billion; its shares were traded at around $14.560000 with and P/S ratio of 856.49. GuruFocus has detected 5 … my secure emr inmediataWebINOVIO Pharmaceuticals, Inc. 4 years 2 months Chief Executive Officer May 2024 - Present1 year Plymouth Meeting, Pennsylvania, United States Chief … my secure emr inmediata loginWebApr 3, 2024 · At INOVIO, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. my secure chartWebMay 11, 2024 · Inovio's Kim out as CEO, company shifts focus from Covid-19 vaccine to booster By John George – Senior Reporter, Philadelphia Business Journal May 11, 2024 In … my secure businessWebMar 12, 2024 · Effective immediately, Inovio's global clinical and R&D functions will report to Dr. Laurent Humeau, Inovio's Chief Scientific Officer and Executive Vice President. As a part of this... my secure boot state says unsupportedWebAug 19, 2015 · INOVIO Pharmaceuticals, Inc. Jun 2009 - Present13 years 11 months Member of the Board of Trustees International Vaccine Institute (IVI) Nov 2013 - Feb 20246 years 4 months Chair, Compensation... the sheep dog